Share on StockTwits

CAS Medical Systems (NASDAQ:CASM) CEO Thomas M. Patton acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The shares were purchased at an average cost of $1.54 per share, for a total transaction of $15,400.00. Following the transaction, the chief executive officer now directly owns 550,177 shares in the company, valued at approximately $847,273. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CAS Medical Systems (NASDAQ:CASM) traded up 6.12% during mid-day trading on Tuesday, hitting $1.56. 156,663 shares of the company’s stock traded hands. CAS Medical Systems has a 52 week low of $1.211 and a 52 week high of $2.50. The stock’s 50-day moving average is $1.81 and its 200-day moving average is $2.06. The company’s market cap is $30.0 million.

CAS Medical Systems (NASDAQ:CASM) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.02. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $5.00 million. Analysts expect that CAS Medical Systems will post $-0.48 EPS for the current fiscal year.

CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.